Read full text on docs.house.gov

Hello! You're looking at a policy document report on Overton

We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work.

If you fund, produce or manage research or work to influence policy, we'd love to talk. Learn more on our homepage.

Hearing: Coronavirus Preparedness and Response

House Committees on March 12th 2020

Topics in this document

Health Health sciences Health care Medicine Life sciences Medical specialties Virus Public health Influenza Infection Influenza-like illness Severe acute respiratory syndrome Vaccine Coronavirus Centers for Disease Control and Prevention Antiviral drug Food and Drug Administration National Institute of Allergy and Infectious Diseases Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Biomedical Advanced Research and Development Authority Middle East respiratory syndrome Disease United States Department of Health and Human Services Influenza pandemic Ebola virus disease Health policy Personal protective equipment Health system Emergency

Tags you've given this document

You haven't tagged this document yet.

Citations

This hasn't been cited yet by other documents in the Overton database.

This document is made up of multiple PDFs

The references found in each have been combined below. If an item has been cited in more than one PDF then it'll appear more than once, linked to the relevant PDF and page number.

All research cited by this document

See details

National Biodefense Strategy: Additional Efforts Would Enhance Likelihood of Effective Implementation

U.S. Government Accountability Office

1GAO, National Biodefense Strategy: Additional Efforts Would Enhance Likelihood of Effective Implementation, GAO-20-273 (Washington, D.C.: Feb. 19, 2020). https://www.gao.gov/products/GAO-20-273

On page 2 of PDF #4

See details

Opportunities to Reduce Potential Duplication in Government Programs, Save Tax Dollars, and Enhance Revenue

U.S. Government Accountability Office

reduce risks, and prepare for, respond to, and recover from biological incidents that could have catastrophic consequences. GAO, Opportunities to Reduce Potential Duplication in Government Programs, Save Tax Dollars, and Enhance Revenue, GAO-11-318SP (Washington, D.C.: Mar. 1, 2011). https://www.gao.gov/products/GAO-11-318SP

On page 2 of PDF #4

See details

Results-Oriented Cultures: Implementation Steps to Assist Mergers and Organizational Transformations

U.S. Government Accountability Office

GAO-18-427 (Washington, D.C.: June 13, 2018) and Results-Oriented Cultures: Implementation Steps to Assist Mergers and Organizational Transformations, GAO-03-669 (Washington, D.C.: Jul. 2, 2003). https://www.gao.gov/products/GAO-18-427 https://www.gao.gov/products/GAO-03-669

On page 7 of PDF #4

See details

Managing for Results: Key Considerations for Implementing Interagency Collaborative Mechanisms

U.S. Government Accountability Office

in Interagency Groups, GAO-14-220 (Washington, D.C.: Feb. 14, 2014) and Managing for Results: Key Considerations for Implementing Interagency Collaborative Mechanisms, GAO-12-1022 (Washington, D.C.: Sept. 27, 2012). https://www.gao.gov/products/GAO-14-220 https://www.gao.gov/products/GAO-12-1022

On page 8 of PDF #4

See details

Combating Terrorism: Evaluation of Selected Characteristics in National Strategies Related to Terrorism

U.S. Government Accountability Office

10GAO, Combating Terrorism: Evaluation of Selected Characteristics in National Strategies Related to Terrorism, GAO-04-408T (Washington, D.C.: Feb. 3, 2004). https://www.gao.gov/products/GAO-04-408T

On page 9 of PDF #4